Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 231211
                    [Title] => Advocacy heeding call for affordable medicines
                    [Summary] => "We’re just heeding the patients and doctors’ call."


This was the main reason Unilab executives gave as they reaffirmed their commitment to deliver reasonably priced but affordable medicines, particularly for essential products. 


"The doctors and patients’ response has been very encouraging and motivates us to continue our commitment to help bring down the prices of these important products," says James Dio, general manager of Therapharma, one of the divisions of Unilab. 


                    [DatePublished] => 2003-12-11 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 230329
                    [Title] => Therapharma rolls back price of statin
                    [Summary] => Patients taking the cholesterol-lowering statins are in for a Christmas treat as Therapharma announces an 18 to 22 percent price rollback of its brand of simvastatin.  


The drug comes in 10, 20 and 40-mg stock doses. 


James Dio, Therapharma general manager, said they have converted into an actual price rollback the discounts which the company has been giving patients through its Health Plus Value Program. 


"Now, everyone can benefit from this general price reduction," Dio said.


                    [DatePublished] => 2003-12-04 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 226914
                    [Title] => Alleviating healthcare cost
                    [Summary] => Rico M., a 45-year-old entrepreneur, has a relatively profitable business which affords him the basic comforts in life. But since he was diagnosed to have diabetes and elevated cholesterol problems, he didn’t realize that his monthly cost of medicines can dig deep into his budget that would make him forego his regular round of golf and entertainment with friends. 


                    [DatePublished] => 2003-11-06 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 223577
                    [Title] => One year of affordable cholesterol therapy
                    [Summary] => Patients from all over the country who benefited from a reasonably priced cholesterol-lowering therapy wrote letters of gratitude and commendation to Therapharma, a division of Unilab, which introduced an affordable brand of simvastatin a year ago. Therapharma’s simvastatin was priced half or less compared to other brands of statins.


                    [DatePublished] => 2003-10-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

JAMES DIO

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 231211
                    [Title] => Advocacy heeding call for affordable medicines
                    [Summary] => "We’re just heeding the patients and doctors’ call."


This was the main reason Unilab executives gave as they reaffirmed their commitment to deliver reasonably priced but affordable medicines, particularly for essential products. 


"The doctors and patients’ response has been very encouraging and motivates us to continue our commitment to help bring down the prices of these important products," says James Dio, general manager of Therapharma, one of the divisions of Unilab. 


                    [DatePublished] => 2003-12-11 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 230329
                    [Title] => Therapharma rolls back price of statin
                    [Summary] => Patients taking the cholesterol-lowering statins are in for a Christmas treat as Therapharma announces an 18 to 22 percent price rollback of its brand of simvastatin.  


The drug comes in 10, 20 and 40-mg stock doses. 


James Dio, Therapharma general manager, said they have converted into an actual price rollback the discounts which the company has been giving patients through its Health Plus Value Program. 


"Now, everyone can benefit from this general price reduction," Dio said.


                    [DatePublished] => 2003-12-04 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 226914
                    [Title] => Alleviating healthcare cost
                    [Summary] => Rico M., a 45-year-old entrepreneur, has a relatively profitable business which affords him the basic comforts in life. But since he was diagnosed to have diabetes and elevated cholesterol problems, he didn’t realize that his monthly cost of medicines can dig deep into his budget that would make him forego his regular round of golf and entertainment with friends. 


                    [DatePublished] => 2003-11-06 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 223577
                    [Title] => One year of affordable cholesterol therapy
                    [Summary] => Patients from all over the country who benefited from a reasonably priced cholesterol-lowering therapy wrote letters of gratitude and commendation to Therapharma, a division of Unilab, which introduced an affordable brand of simvastatin a year ago. Therapharma’s simvastatin was priced half or less compared to other brands of statins.


                    [DatePublished] => 2003-10-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Advocacy heeding call for affordable medicines

December 11, 2003 - 12:00am

"We’re just heeding the patients and doctors’ call." This was the main reason Unilab executives gave as they reaffirmed their commitment to deliver reasonably priced but affordable medicines,...

Science and Environment

Therapharma rolls back price of statin

December 4, 2003 - 12:00am

Patients taking the cholesterol-lowering statins are in for a Christmas treat as Therapharma announces an 18 to 22 percent price rollback of its brand of simvastatin. The drug comes in 10, 20 and 40-mg stock doses....

Science and Environment

Alleviating healthcare cost

November 6, 2003 - 12:00am

Rico M., a 45-year-old entrepreneur, has a relatively profitable business which affords him the basic comforts in life. But since he was diagnosed to have diabetes and elevated cholesterol problems, he didn’t...

Science and Environment

One year of affordable cholesterol therapy

October 9, 2003 - 12:00am

Patients from all over the country who benefited from a reasonably priced cholesterol-lowering therapy wrote letters of gratitude and commendation to Therapharma, a division of Unilab, which introduced an affordable...

Science and Environment